Document Detail


Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease.
MedLine Citation:
PMID:  17316339     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hydroxyurea (HU) is not infrequently used in patients with sickle cell disease and myeloproliferative disorders. Despite murine data showing adverse effects on sperm counts, motility and morphology, there is little information on the effect of HU on human spermatogenesis. A retrospective review of four adult men who had semen analysis during HU therapy and in three cases after its cessation suggests that HU generally reduces sperm counts and motility and results in abnormal morphology. Cessation of HU in one case with azoospermia resulted in recovery of spermatogenesis; in two of the three cases, however, sperm morphology and mobility remained impaired. Recommendations for fertility management in adult men receiving long-term HU therapy are proposed.
Authors:
A Grigg
Related Documents :
3391979 - Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
19865069 - Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic a...
9641379 - Secondary sympathetic chain reconstruction after endoscopic thoracic sympathicotomy.
19166599 - A patient with superior semicircular canal dehiscence presenting with tullio's phenomen...
15688689 - A combined use of acupuncture, moxibustion and long dan xie gan tang for treatment of 3...
20815749 - A literature review of transmission effectiveness and electromagnetic compatibility in ...
10885629 - The design of the prenatal determinants of schizophrenia study.
17725109 - Acral myxoinflammatory fibroblastic sarcoma of the foot.
12784079 - Cortical ependymoma. a case report and review.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Internal medicine journal     Volume:  37     ISSN:  1445-5994     ISO Abbreviation:  Intern Med J     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-23     Completed Date:  2007-03-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101092952     Medline TA:  Intern Med J     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  190-2     Citation Subset:  IM    
Affiliation:
Department of Clinical Haematology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia. andrew.grigg@mh.org.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anemia, Sickle Cell / drug therapy*,  pathology,  physiopathology
Antisickling Agents / adverse effects*,  therapeutic use
Azoospermia / chemically induced
Humans
Hydroxyurea / adverse effects*,  therapeutic use
Male
Myeloproliferative Disorders / drug therapy*,  pathology,  physiopathology
Nucleic Acid Synthesis Inhibitors / adverse effects*,  therapeutic use
Oligospermia
Retrospective Studies
Sperm Count
Sperm Motility / drug effects
Spermatozoa / drug effects*,  ultrastructure
Chemical
Reg. No./Substance:
0/Antisickling Agents; 0/Nucleic Acid Synthesis Inhibitors; 127-07-1/Hydroxyurea

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Critical review of the management of early-stage breast cancer in elderly women.
Next Document:  Urgent liver transplantation for acute liver failure due to parvovirus B19 infection complicated by ...